Live Courses

This course is intended for endocrinologists, neurosurgeons, radiation oncologists, ophthalmologists, neuro-oncologists, family medicine and internal medicine physicians, physicians in training and other allied health professionals who treat and manage patients with pituitary diseases.

Non-alcoholic fatty liver disease (NAFLD) encompasses simple steatosis to more progressive steatosis with associated hepatitis, fibrosis, cirrhosis, and in some cases, hepatocellular carcinoma (HCC). NAFLD is a worldwide growing epidemic. Currently, decision making is difficult for clinicians because of the rapidly evolving landscape for the screening, diagnosis, management, and treatment of NAFLD and nonalcoholic steatohepatitis (NASH). There is a significant need for clinician education in NAF...

Non-alcoholic fatty liver disease (NAFLD) encompasses simple steatosis to more progressive steatosis with associated hepatitis, fibrosis, cirrhosis, and in some cases, hepatocellular carcinoma (HCC). NAFLD is a worldwide growing epidemic. Currently, decision making is difficult for clinicians because of the rapidly evolving landscape for the screening, diagnosis, management, and treatment of NAFLD and nonalcoholic steatohepatitis (NASH). There is a significant need for clinician education in NAF...

This educational activity is designed for general gastroenterologists who manage patients with inflammatory bowel disease, viral hepatitis, NAFLD and general GI and liver disorders. We anticipate 250 live participants and over 100 virtual participants via the GUILD custom built virtual platform.

This 4-day, comprehensive CME activity will utilize evidence-based data around the management of rheumatic diseases.  Didactic teaching, interactive discussion/panels, case-based discussions and workshops will enhance the relevancy providing rheumatologists with the ability to apply the latest data into clinical practice. This conference will be offered live and virtual.